1 .US Patent Series No. 60/607, 320. J Wang, P.  Gao, GW Lu,:  Self Emulsifying Composition For

Delivering Lipophilic Active Ingredients.

2. Chinese Patent  ZL2005 8 0029556.2 王小曾 用自乳化制剂释放亲脂性辅酶CoQ10及其他膳食组份.

3. US 6,121,313. P.Gao and W.Morozowich. Pharmaceutical composition in a form of self-emulsifying formulation for acidic    lipophilic compounds.

4. US 6,231,887 B1. P.Gao and W.Morozowich. Pharmaceutical composition for lipophilic compounds in a form of self-  emulsifying formulation.

5.US 6,451,838 B1. M.W.Moon, W.Morozowich, P.Gao. 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives.

6.US 6,482,848 B2.  Prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao, M.Koenig.

7.US 6,531,139 B1. P.Gao, W.Morozowich.  Self-emulsifying formulation for lipophilic compounds.

8.US 6,579,895 B2. A.Karim, A.M.Brugger, P.Gao, F.Hassan, and J.C.Forbes. Use of a celecoxib composition for fast pain relief

9.EP 0989 851 B1. W.Morozowich and P.Gao. Self-emulsifying formulation for acidic lipophilic compounds.

10.EP 0999 838 B1. W.Morozowich and P.Gao. Self-emulsifying formulation for lipophilic compounds.

11.WO 01/90068 A2. Mannich base prodrug of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao, P.C.Tang.

12.WO 01/90104 A2.  Prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao.

13.Yunguo Gong, Chaoneng Wu, Qinghe Xing, Xinzhi Zhao, Jun Zhu, Lin He. A two-method Meta analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophrenia Research. 2009, 111 (1-3):109-114. (Research article, IF4.6, cited times 36)

 

14.Chaoneng Wu, Yunguo Gong, Jie Yuan, Hui Gong, Yunzeng Zou, Junbo Ge. Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies. Cardiovasc Diabetol. 2012, 14;11 (1):68-80. (Research article, co-first author, IF4.0, cited times 6)